The effects of non-selective and cyclooxygenase-2-selective non-steroidal anti-inflammatory drugs on heterotopic ossification in rats

Medical Science Monitor

Volumn 11, Issue 12, 2005, Pages

  Murat, Nergiz ^a   Hocaoglu, Nil ^a   Karatosun, Vasfi ^a   Yorukoglu, Kutsal ^a   Gidener, Sedef ^a   Gunal, Izge ^a,b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

COX 2 inhibitors; Heterotopic ossification; NSAIDs; Rat

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; METHYLCELLULOSE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DEMINERALIZATION; CONTROLLED STUDY; DRUG EFFECT; FEMUR; GLUTEUS MAXIMUS MUSCLE; HETEROTOPIC OSSIFICATION; MALE; NONHUMAN; OSSIFICATION; POSTOPERATIVE PERIOD; RAT; REVIEW; TIBIA SHAFT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; FURANS; INDOMETHACIN; MALE; OSSIFICATION, HETEROTOPIC; RATS; RATS, WISTAR;

EID: 31344472843     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Reardon MJ, Tillou A, Mody DR, Reardon PR: Heterotopic calcification in abdominal wounds. Am J Surg, 1997; 173: 145-47
2. Ross N, Tacconi L, Miles JB: Heterotopic bone formation causing recurrent donor site pain following iliac crest bone harvesting. Br J Neurosurg, 2000; 14: 476-79
3. Gunal I, Hazer B, Seber S et al: Prevention of heterotopic ossification after total hip replacement. A prospective comparison of indomethacin and salmon calcitonin in 60 patients. Acta Orthop Scand, 2001; 72: 467-69
4. Knelles D, Barthel T, Karrer A et al: Prevention of heterotopic ossification after total hip replacement. A prospective randomized study using acetyl-salicylic acid indomethacin and fractional or single-dose irradiation. J Bone Joint Surg, 1997; 79-B: 596-602
5. Sodemann B, Persson P-E, Nilsson OS: Prevention of heterotopic ossification by nonsteroidal antiinflammatory drugs after total hip arthroplasty. Clin Orthop, 1988; 237: 158-63
6. Raisz LG: Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med, 2001;110:43S-45S
7. Törnkvist H, Baver FCH, Nilsson OS: influence of indomethacin on experimental bone metabolism in rats. Clin Orthop, 1985; 193: 264-70
8. Bobrzyński A, Konturek PC, Konturek SJ et al: Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers. Med Sci Monit, 2005; 11(3): CR132-CR135
9. FitzGerald GA, Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Eng J Med, 2001; 345: 433-42
10. Juni P, Nartey L, Reichenbach S et al: Risk of cardiovascular events and rofecoxib: meta-analysis. Lancet, 2004; 364: 2021-29
11. Gerstenfeld LC, Thiede M, Seibert K et al: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. J Orthop Res, 2003; 21: 670-75
12. Simon AM, Manigrasso MB, O'Connor JP: Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Min Res, 2002; 12: 963-76
13. Zhang X, Schwartz EM, Young DA et al: Cyclooxygenase-2 regulates mesanchymal cell differentiation action into the osteoblast lineage and is critically involved in bone repair. J Clin Invest, 2002; 109: 1405-15
14. Riendau D, Percival MD, Boyce S et al: Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol, 1993; 121: 105-17
15. Urist MR, Hay PH, Dubuc F, Buring K: Osteogenic competence. Clin Orthop, 1969; 64: 194-220
16. Chalmers J, Gray DH: Observations on the induction of bone in soft tissues. J Bone Joint Surg, 1975; 57-B: 36-45
17. Nilsson OS, Baver HCF, Brosjö O, Törnkvist H: Influence of indomethacin on induced heterotopic bone formation in rats. Importance of length of treatment and of age. Clin Orthop, 1986; 207: 239-45
18. Nilsson OS, Persson P-E, Ekelund A: Heterotopic new bone formation causes resorption of the inductive bone matrix. Clin Orthop, 1990; 257: 280-85
19. Jouzeau JY, Terlain B, Abid A et al: Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs? Drugs, 1997; 53: 563-82
20. Zacher JE, Walter E, Gursche A: Prevention of periarticular ossification after total hip replacement with refocoxib 25 mg. EULAR Congress 13-16 June 2001, Praque
21. Puzas JE, Miller MD, Rosier RN: Pathologic bone formation. Clin Orthop, 1989; 245: 269-81